Obesity Clinical Trial
Official title:
Factors Associated With Chronic Respiratory Failure in Obesity: A Cross-sectional Study
Some overweight individuals develop problems with their breathing such that they gradually
breathe less and less. This leads to a lack of oxygen and a buildup of carbon dioxide in the
blood, called ventilatory failure. As a consequence, if such a person develops a chest
infection, they are more likely to become seriously ill and need intensive care. In addition
they are much more likely to develop severe complications during and following operations.
This problem can be treated with a machine at home used overnight to help breathing. It is
interesting that ventilatory failure only happens in some overweight individuals, and the
investigators do not understand what factors make this complication develop. There are a
number of theories: for example the distribution of the fat, additional lung disease (such as
asthma), the addition of obstructive sleep apnoea, a condition when there are periods of
cessation of breathing overnight (which is more common in obese individuals), weak muscles of
breathing (perhaps due to fatty infiltration of muscles or vitamin D deficiency), and other
hormonal changes.
The investigators intend to measure many potential factors in a range of overweight
individuals, some who have ventilatory failure, and some who do not, to try and work out
which are the important factors that cause this problem. If the investigators can identify
such factors, then this will help predict in advance who is at risk from chest infections and
during operations; thus allowing for earlier provision of an overnight breathing machine.
This should reduce complications and potentially deaths in such individuals.
To test the hypothesis that in obese patients with obesity-hypoventilation (OHS) there are specific factors related to the development of ventilatory failure, compared to obese subjects not in ventilatory failure ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |